ZIMLABNSEZim Laboratories LimitedMinimalNeutral
Announced Wed, 20 May · 13:01 IST

Zim Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

ZIMLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.5%1-day move
₹102.00
prior close
₹103.05
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0-1.5-2.5-2.5+2.0+0.6+1.0+9.8+22.9+18.6
Up moveDown movePending
AI summary

ZIM Laboratories Limited has published its financial results for Q4 and full year ended March 2026 in newspapers (Financial Express, Indian Express, Loksatta) as required under SEBI regulations. For the standalone results, income from operations was Rs. 10.26 crore in Q4 FY26 with profit after tax of Rs. 4.04 lakh. For the full year FY26, standalone income from operations was Rs. 4.01 crore with profit after tax of Rs. 62.10 lakh. Consolidated earnings per share for FY26 stood at Rs. 2.50 (basic and diluted). The audit committee reviewed the results on May 18, 2026 and the board approved them on May 19, 2026. The audit report for the year ended March 31, 2026 contains no qualifications, which is a positive sign.

Likely market impact

The company remains profitable for FY26 with no audit qualifications, which should be viewed positively by investors. The filing is a mandatory disclosure requirement and confirms Q4 and full year performance data has been publicly released.